Healthcare provider profile · identity verified

Adam Stubert, M.D.

Family Practice · NEW CASTLE, PA · NPI 1467832931

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	608	153
Rosuvastatin Calcium	Rosuvastatin Calcium	459	117
Pantoprazole Sodium	Pantoprazole Sodium	456	101
Levothyroxine Sodium	Levothyroxine Sodium	454	106
Amlodipine Besylate	Amlodipine Besylate	420	119
Omeprazole	Omeprazole	344	82
Lisinopril	Lisinopril	325	83
Fluticasone Propionate	Fluticasone Propionate	237	90
Gabapentin	Gabapentin	233	58
Tamsulosin Hcl	Tamsulosin Hcl	230	50
Hydrochlorothiazide	Hydrochlorothiazide	222	68
Losartan Potassium	Losartan Potassium	204	53
Ozempic	Semaglutide	193	42
Sertraline Hcl	Sertraline Hcl	192	49
Metformin Hcl Er	Metformin Hcl	184	50
Duloxetine Hcl	Duloxetine Hcl	180	48
Albuterol Sulfate Hfa	Albuterol Sulfate	170	47
Metformin Hcl	Metformin Hcl	151	48
Famotidine	Famotidine	150	31
Furosemide	Furosemide	147	44
Potassium Chloride	Potassium Chloride	146	42
Allopurinol	Allopurinol	143	34
Eliquis	Apixaban	142	30
Xarelto	Rivaroxaban	139	27
Metoprolol Tartrate	Metoprolol Tartrate	123	34
Jardiance	Empagliflozin	116	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	113	25
Atenolol	Atenolol	111	30
Simvastatin	Simvastatin	109	32
Trazodone Hcl	Trazodone Hcl	106	34
Zolpidem Tartrate	Zolpidem Tartrate	105	14
Glimepiride	Glimepiride	103	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	99	21
Lorazepam	Lorazepam	97	19
Prednisone	Prednisone	95	54
Carvedilol	Carvedilol	94	23
Ibuprofen	Ibuprofen	94	22
Metoprolol Succinate	Metoprolol Succinate	94	29
Warfarin Sodium	Warfarin Sodium	84	suppressed
Synthroid	Levothyroxine Sodium	81	18
Fluoxetine Hcl	Fluoxetine Hcl	80	21
Tramadol Hcl	Tramadol Hcl	77	22
Montelukast Sodium	Montelukast Sodium	76	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	19
Alendronate Sodium	Alendronate Sodium	69	21
Clopidogrel	Clopidogrel Bisulfate	69	16
Escitalopram Oxalate	Escitalopram Oxalate	69	18
Alprazolam	Alprazolam	68	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	12
Meloxicam	Meloxicam	64	18
Triamcinolone Acetonide	Triamcinolone Acetonide	64	38
Olmesartan Medoxomil	Olmesartan Medoxomil	61	17
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	60	14
Oxycodone Hcl	Oxycodone Hcl	60	suppressed
Celecoxib	Celecoxib	56	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Pravastatin Sodium	Pravastatin Sodium	51	17
Colchicine	Colchicine	50	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	50	42
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	50	suppressed
Diclofenac Sodium	Diclofenac Sodium	49	21
Ipratropium Bromide	Ipratropium Bromide	49	25
Ketoconazole	Ketoconazole	48	19
Ondansetron Hcl	Ondansetron Hcl	46	25
Trulicity	Dulaglutide	45	13
Chlorthalidone	Chlorthalidone	44	14
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Spironolactone	Spironolactone	44	12
Esomeprazole Magnesium	Esomeprazole Magnesium	43	13
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	43	13
Valsartan	Valsartan	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Humalog Kwikpen U-100	Insulin Lispro	40	suppressed
Azithromycin	Azithromycin	39	30
Ezetimibe	Ezetimibe	39	suppressed
Glipizide Er	Glipizide	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Baclofen	Baclofen	33	suppressed
Methylprednisolone	Methylprednisolone	32	27
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	24
Ondansetron Odt	Ondansetron	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	suppressed
Doxepin Hcl	Doxepin Hcl	30	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Donepezil Hcl	Donepezil Hcl	28	13
Januvia	Sitagliptin Phosphate	28	suppressed
Sucralfate	Sucralfate	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	12
Meclizine Hcl	Meclizine Hcl	25	13
Mirtazapine	Mirtazapine	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Cefuroxime	Cefuroxime Axetil	22	18
Methocarbamol	Methocarbamol	22	suppressed
Naproxen	Naproxen	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Metronidazole	Metronidazole	21	suppressed
Mupirocin	Mupirocin	21	15
Pregabalin	Pregabalin	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Triazolam	Triazolam	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	11
Finasteride	Finasteride	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Phenytoin	Phenytoin	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Klayesta	Nystatin	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	17	suppressed
Wegovy	Semaglutide	17	suppressed
Cephalexin	Cephalexin	16	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nystatin	Nystatin	15	12
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Topiramate	Topiramate	15	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ibu	Ibuprofen	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Primidone	Primidone	13	suppressed
Temazepam	Temazepam	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error